Search

Date 2016 Author/Creator Lock, Richard

2. Initial Testing (Stage 1) of MK‐8242—A Novel MDM2 Inhibitor—by the Pediatric Preclinical Testing Program. Issue 10 (30th May 2016)

Authors:
Kang, Min H.; Reynolds, C. Patrick; Kolb, E. Anders; Gorlick, Richard; Carol, Hernan; Lock, Richard; Keir, Stephen T.; Maris, John M.; Wu, Jianwrong; Lyalin, Dmitry; Kurmasheva, Raushan T.; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 63:Issue 10(2016)
Page Start:
1744
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program. Issue 4 (21st September 2016)

Authors:
Lock, Richard; Carol, Hernan; Maris, John M.; Kolb, E. Anders; Gorlick, Richard; Reynolds, C. Patrick; Kang, Min H.; Keir, Stephen T.; Wu, Jianrong; Purmal, Andrei; Gudkov, Andrei; Kurmashev, Dias; Kurmasheva, Raushan T.; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 4(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗